Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Pfenex Inc. holds a patent portfolio within the Biotechnology & Pharmaceuticals technology area. The company's current prosecution status includes 1 pending office action. This action is situated within 1 distinct art unit, reflecting a concentrated technical scope for the pending matter.
The prosecution is overseen by 1 distinct examiner, JESSICA FAYE EDWARDS. This examiner is designated as the busiest examiner, holding 1 busiest examiner pending action. With only 1 pending office action in the entire portfolio, the workload is concentrated under the 1 distinct examiner. Practitioners should note that the 1 busiest examiner pending action accounts for all current activity at the patent office for this company. The use of 1 distinct art unit for the pending office action indicates a lack of departmental diversity in the company's current patent filings. This profile represents a streamlined prosecution path where all current results depend on the 1 distinct examiner.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EDWARDS, JESSICA FAYE | 1 | 39.1% | +46.4% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17559978 | METHODS OF PURIFYING CHARGE-SHIELDED FUSION PROTEINS | EDWARDS, JESSICA FAYE | 23d overdue |
| Art Unit | Apps |
|---|---|
| 1657 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17559978 | METHODS OF PURIFYING CHARGE-SHIELDED FUSION PROTEINS | EDWARDS, JESSICA FAYE | 1657 | §103 | Final Rejection | 23d overdue | Pending | Dec 22, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial